Thermal degradation of polyethylene glycol 6000 and its effect on the assay of macroprolactin

被引:8
作者
Boughen, Louise [1 ]
Liggat, John [2 ]
Ellis, Graham [1 ]
机构
[1] St Johns Hosp, Dept Clin Biochem, Livingston EH54 6PP, West Lothian, Scotland
[2] Univ Strathclyde, Dept Pure & Appl Chem, Glasgow G1 1XL, Lanark, Scotland
关键词
Prolactin; Polyethylene glycols; Humans; Reproducibility of results; Magnetic resonance spectroscopy; Temperature; AIR OXIDATION;
D O I
10.1016/j.clinbiochem.2010.02.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: To study the effectiveness of partially degraded polyethylene glycol 6000 (PEG) as a precipitant for macroprolactin. Design and methods: PEG was heated to 63 degrees C in air for up to 20 days and its effectiveness assessed as a precipitant for sera containing normal prolactin or macroprolactin. Decomposition was studied chemically and with NMR spectroscopy. Results: Thermal degradation was similar to what had occurred over several years of natural degradation. Initially PEG degraded 2-5 days caused excess precipitation of monomeric prolactin (false-positive macroprolactinemia). Samples degraded 18-20 days failed to precipitate macroprolactin, giving false negative results. Two H-1 NMR peaks at 4-4.5 ppm were not detectable in undegraded PEG but were after 1 day. Their relative integral increased to 20 days. Conclusions: Aging of PEG can be accelerated by heating. The suitability of PEG for use in macroprolactin assays can be assessed by the absence of peaks at 4-4.5 ppm by H-1 NMR. (C) 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:750 / 753
页数:4
相关论文
共 9 条
[1]  
[Anonymous], 1991, INTRO POLYM, DOI DOI 10.1007/978-1-4899-3176-4
[2]   Formation of formaldehyde and peroxides by air oxidation of high purity polyoxyethylene surfactants [J].
Bergh, M ;
Magnusson, K ;
Nilsson, JLG ;
Karlberg, AT .
CONTACT DERMATITIS, 1998, 39 (01) :14-20
[3]   Degradation of crystalline polyethylene glycol 6000 and its effect on assays for macroprolactin and other analytes [J].
Ellis, Graham .
CLINICAL BIOCHEMISTRY, 2006, 39 (10) :1035-1040
[4]   Macroprolactin; high molecular mass forms of circulating prolactin [J].
Fahie-Wilson, MN ;
John, R ;
Ellis, AR .
ANNALS OF CLINICAL BIOCHEMISTRY, 2005, 42 :175-192
[5]  
Germano L, 2005, CLIN CHIM ACTA, V355, pS262
[6]   Thermal/oxidative degradation and stabilization of polyethylene glycol [J].
Han, S ;
Kim, C ;
Kwon, D .
POLYMER, 1997, 38 (02) :317-323
[7]  
HATTORI N, 2009, CLIN ENDOCRINOL 0528
[8]  
Otal E, 1997, J CHEM TECHNOL BIOT, V70, P147
[9]   Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: Application of a new strict laboratory definition of macroprolactinemia [J].
Suliman, AM ;
Smith, TP ;
Gibney, J ;
McKenna, TJ .
CLINICAL CHEMISTRY, 2003, 49 (09) :1504-1509